|
|
Amgen Inc CDR
TSX •
Healthcare •
Drug Manufacturers - General •
Quote as of 09/08/2026 15:59
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeTSX
Market Capitalization317,854 mln
Float9,815 mln
Earnings Date11/03/2026
P / E
23.61
Premium valuation
Key Fundamentals
EPS1.23
P/E23.61
ROE93.84
ROIC14.80
ROA9.57
Interest Cover4.28
EBITDA, mln24,412
EV / EBITDA15.72
EV / EBIT21.39
Revenue, mln52,765
EV / Revenue7.27
Financial Strength
Altman Z-Score2.31
Piotroski F-Score
8
/ 9
Beneish M-Score-2.62
Price to Intrinsic Value1.87
Price to Lynch Fair Value1.90
Shiller PE Ratio33.08
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-8.7% |
3
/ 100
 |
| 1 Month |
-2.92% |
22
/ 100
 |
| 2 Months |
17.53% |
92
/ 100
 |
|
| |
